Lilly Turns From One Company Veteran to Another for New CEO

  • Ricks has led medicines unit, held M&A and marketing roles
  • Lechleiter started as organic chemist at drugmaker in 1979

Over the last eight years, Eli Lilly & Co. relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now it’s turned to another long-time executive for its next chapter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.